#Transfection Technologies Market news
Explore tagged Tumblr posts
Text
Industry Deep Dive: Transfection Technologies Market Size, Share, and Growth Forecast with Emerging Trends through 2032
Global Transfection Technologies Market size and share is currently valued at USD 1.08 billion in 2023 and is anticipated to generate an estimated revenue of USD 2.33 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 9.0% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032
Our newly published research report titled Transfection Technologies Market Insights offers a comprehensive analysis of the rapidly growing market. It highlights all the key factors anticipated to drive growth while shedding light on potential challenges and opportunities that could emerge in the market in the upcoming years. The market assessment includes a thorough analysis of Transfection Technologies market share, size, gross margin, and CAGR. The research report has been prepared using industry-standard methodologies to offer a thorough assessment of the major market participants and their market scope.
All the data and information provided in the study are curated and verified by expert analysts to provide a reliable and accurate market analysis. Also, pictorial representations such as tables, charts, and graphs have been used to enhance decision making and improve business strategy. The research report is a must-read for anyone involved or interested in the market in any form.
Key Report Features:
Comprehensive Market Data: Provides a thorough market examination of annual sales, current market size, and anticipated Transfection Technologies market growth rate during the forecast period.
Regional Analysis: Thorough analysis of all the major regions and sub-regions in the market.
Company Profiles: An in-depth assessment of all the leading market participants and emerging businesses.
Customization: Report customization as per your requirements with respect to countries, regions, and segmentation.
Major Market Participants:
The research report includes a comprehensive competitive landscape section that helps businesses understand their competitors and the market in which they operate. All the major Transfection Technologies market players have been covered in the report. By going through the competitive landscape, businesses can identify their competitors and understand their strengths and weaknesses. Also, businesses can better examine the products/services of their competitors and evaluate their offers and pricing. All the major competitive analysis frameworks, including SWOT analysis and PESTEL analysis, have been included in the research study to offer a thorough assessment of the market’s competitive scenario. Here are a few of the key players operating in the market:
Browse Full Insights
The top players operating in the market are:
Altogen Biosystems
Bio-Rad Laboratories, Inc.
GenScript Biotech Corporation
Lonza Group Ltd.
MaxCyte, Inc.
Merck KGaA
Mirus Bio LLC
OriGene Technologies, Inc.
Polyplus-transfection SA
Promega Corporation
QIAGEN N.V.
SignaGen Laboratories
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Viromer
Market Dynamics:
Growth Drivers: The research report sheds light on all the major factors driving the robust growth of the market. Also, all the key trends and opportunities anticipated to have a favorable impact on market Transfection Technologies development have been covered in the study.
Technological Advancements: All the major advances in technology that can support market growth have been covered in the research report. Besides, the introduction of new products/services by major participants has been detailed.
Regulatory Policies: The research report examines the regulatory landscape of the constantly evolving market, shedding light on new market frameworks and policies projected to drive the market forward.
Segmental Overview:
1. By Type of Transfection
Chemical Transfection:
Lipofection: Uses lipid-based reagents to deliver nucleic acids (e.g., DNA, RNA) into cells.
Polymer-Based Transfection: Utilizes synthetic polymers to form complexes with DNA or RNA for cell entry.
Calcium Phosphate Transfection: A method involving calcium phosphate to facilitate DNA transfer into cells.
Other Chemical Transfection Methods: Includes other chemical reagents and techniques such as DEAE-dextran and cationic lipids.
Physical Transfection:
Electroporation: Uses an electrical field to increase the permeability of the cell membrane, allowing nucleic acids to enter.
Microinjection: Direct injection of nucleic acids into cells using a fine needle.
Gene Gun (Biolistic): Uses high-pressure helium to shoot DNA-coated particles into cells.
Sonoporation: Uses ultrasound waves to enhance the uptake of genetic material into cells.
Biological Transfection:
Viral Transfection: Uses modified viruses, like lentiviruses or adenoviruses, to deliver genetic material into cells.
Bacterial Transfection: Involves using bacteria, such as E. coli or other microbial vectors, to introduce DNA or RNA into target cells.
2. By Application
Gene Therapy:
The use of transfection techniques to introduce therapeutic genes into patients to treat genetic disorders, such as cystic fibrosis, hemophilia, and certain cancers.
Vaccines Development:
Transfection methods are employed in the development of DNA and RNA vaccines, particularly for diseases like COVID-19, cancer, and other infectious diseases.
Drug Development and Delivery:
Transfection technologies are used in drug research for cell-based assays, gene editing, and the delivery of therapeutic molecules such as siRNA, mRNA, and proteins.
Biopharmaceutical Production:
Transfection is used in the production of biologics and recombinant proteins, including monoclonal antibodies and enzymes.
Stem Cell Research:
Transfection plays a critical role in stem cell research by facilitating gene modification and inducing pluripotency in stem cells.
Protein Expression and Cell Line Development:
Transfection is used to create stable cell lines that produce specific proteins for research or therapeutic applications.
CRISPR Gene Editing:
Transfection techniques are crucial for introducing CRISPR-Cas9 components (e.g., guide RNA, Cas9 protein) into target cells for gene editing purposes.
3. By End-User
Pharmaceutical and Biopharmaceutical Companies:
Key users of transfection technologies for drug development, gene therapies, and vaccine production.
Academic and Research Institutions:
Leading consumers of transfection technologies for molecular biology research, gene editing, and cell line development.
Contract Research Organizations (CROs):
CROs use transfection for preclinical studies, gene expression analysis, and development of gene-based therapies.
Hospitals and Clinics:
In gene therapy and clinical trials for various genetic disorders, gene therapy applications are increasingly being adopted.
Agricultural Biotechnology:
Transfection methods are used in agricultural research to modify crops or create genetically modified organisms (GMOs).
Report Answers Questions Such As:
• What is the current market size and projected value? • What are the major factors driving Transfection Technologies market sales and demand? • What are the key developments and trends driving the market forward? • What are the key outcomes of the PESTEL analysis for the market? • Who are the major players offering their products/services in the market? • What are the major opportunities that market participants can capitalize on?
Report Summary:
The Transfection Technologies market research report is a reliable resource to understand the dynamic nature of the market. It covers several key market features, including capacity, revenue, price, consumption, production rate, and supply demand, to provide an in-depth market analysis. By going through the research study, readers can get a precise and reliable analysis of the rapidly evolving market.
More Trending Latest Reports By Polaris Market Research:
Fructose Market
Protein A, G and L Resins Market
District Cooling Market
Coating Additives Market
Ethylene Carbonate Market
Audiobooks Market
U.S. Protein Bar Market
Zinc-ion Battery Market
0 notes
Text
Future of U.S. Cell Culture Market: Insights from Industry Experts
The U.S. cell culture market size is anticipated to reach USD 10.97 billion by 2030 and is projected to grow at a CAGR of 10.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is expected to be driven by various factors, such as the growth of biosimilars and biologics, advancements in stem cell research, and the emergence of bio-manufacturing technologies that facilitate the development of cell-based vaccines.
The COVID-19 pandemic has resulted in an increased demand for reliable cell-based vaccine production technologies. Furthermore, it has led to a few notable scientific breakthroughs, particularly in the development and testing of vaccine technologies. In August 2021, Danaher announced the manufacturing expansion of Cytiva and Pall which assisted in the drug and vaccine development for COVID and enabled expansion in manufacturing of various modalities such as cell culture and gene therapy to meet the demands during the pandemic.
Cell culture technology has witnessed significant advancements over the past few years and the technology is witnessing a rapid expansion in its scope of applications. In the field of biopharmaceuticals, researchers can now produce complex protein-based drugs in large quantities due to the ability to culture mammalian cells. This has led to increased efficiency, reduced costs, and improved quality control in the biopharmaceutical industry. Furthermore, the launch of high-yield cell lines and the optimization of culture conditions have contributed to enhanced productivity and scalability. For instance, in June 2023, Matica Bio launched its MatiMax cell lines at the BIO International Convention. The cell line features faster doubling times to reduce processing timelines, has enhanced transfection efficiencies, and enables increased titer production at a lower cost.
Gather more insights about the market drivers, restrains and growth of the U.S. Cell Culture Market
U.S. Cell Culture Market Report Highlights
• The consumables segment led the market with the largest revenue share of 58.0% in 2023 and are expected to grow at the fastest CAGR during the forecast period. This is attributed to the increased R&D expenditure by biotechnology & biopharmaceutical businesses to develop sophisticated biologics, such as monoclonal antibodies & vaccines
• Based on application, the biopharmaceutical production segment led the market with the largest revenue share of 31.9% in 2023 and is expected to grow at the fastest CAGR during the forecast period. The technological advancements in antibody therapeutics, such as the development of bispecific antibodies, antibody fragments, and antibody derivatives, are anticipated to expand the market prospects for applications of cell culture
U.S. Cell Culture Market Segmentation
Grand View Research has segmented U.S. cell culture market based on product, and application:
U.S. Cell Culture Product Outlook (Revenue, USD Million, 2018 - 2030)
• Consumables
o Sera
o Reagents
o Media
o Instruments
U.S. Cell Culture Application Outlook (Revenue, USD Million, 2018 - 2030)
• Biopharmaceutical Production
o Monoclonal Antibodies
o Vaccines Production
o Other Therapeutic Proteins
• Drug Development
• Diagnostics
• Tissue Culture & Engineering
• Cell & Gene Therapy
• Toxicity Testing
• Other Applications
Order a free sample PDF of the U.S. Cell Culture Market Intelligence Study, published by Grand View Research.
#U.S. Cell Culture Market#U.S. Cell Culture Market Size#U.S. Cell Culture Market Share#U.S. Cell Culture Market Analysis#U.S. Cell Culture Market Growth
0 notes
Text
https://www.advancemarketanalytics.com/reports/64636-global-flow-cytometry-market-1
2024 Review: Flow Cytometry Market Global Scenario and Development Activity
Advance Market Analytics released a new market study on Global Flow Cytometry Market Research report which presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates for Global Flow Cytometry Forecast till 2029*.
Growth in the use of flow cytometry in stem cell research will help to boost the global flow cytometry market. Flow cytometry is a method used to identify and measure the physical and chemical features of a population of cells or particles. Additionally, it is used in cell counting, cell sorting, detecting biomarker, and protein engineering. There is a large void in diagnostics accessibility, particularly in the developing regions. So, the growing incidences of HIV AIDS and cancer can be measured a substantial growth opportunity for the global flow cytometry market.
Key Players included in the Research Coverage of Flow Cytometry Market are:
Becton, Dickinson and Company (United States), Thermo Fisher Scientific, Inc. (United States), Beckman Coulter, Inc. (United States), Merck KGaA (Germany), Luminex Corporation , Sysmex Partec GmbH (Germany), Miltenyi Biotec GmbH (Germany), Agilent Technologies, Inc. (United States), bioMérieux S.A. (France), Bio-Rad Laboratories, Inc. (United States),
What's Trending in Market: The Emergence and Commercial Application of New Technologies in the Field Of Flow Cytometry Intensifying Stem Cell Research Developing Public-Private Initiatives in the Field Of Immunology and Immuno-Oncology Researches
Challenges: Inadequate Research Infrastructure across Emerging CountriesComplexities Related To Reagent Development
Opportunities: Growing Availability of Novel Application-Specific Flow Cytometry Products Increasing Market Presence in Emerging Countries Adoption of Recombinant DNA Technology for Antibody Production
Market Growth Drivers: Growing Prevalence of Cancer and HIV/AIDS Upsurge in the Applications of Flow Cytometry in Clinical ResearchIncreasing Adoption of Flow Cytometry Techniques in Research and Academia
The Global Flow Cytometry Market segments and Market Data Break Down by Type (Cytometry Platforms (Sorters, Analyzers), Replaceable Components (Filter, Laser, Detectors, Others), Accessories, Reagents and Consumables (Antibodies, Dyes, Beads, Solutions, Buffers, Others), Software, Services), Application (Academic and Clinical Research (Cell Cycle Analysis and Cell Proliferation, Apoptosis, Sorting and Screening, Transfection and Cell Viability, Others), Diagnosis (Organ Transplantation, Hematological Malignancies, Cancer and Solid Tumors, Immunodeficiency Diseases- HIV Infection, Others)), Technology (Cell-Based, Bead-Based), End User (Commercial Organizations, Medical Schools and Clinical Labs, Hospitals, Academics, Others)
Get inside Scoop of the report, request for free sample @: https://www.advancemarketanalytics.com/sample-report/64636-global-flow-cytometry-market-1
To comprehend Global Flow Cytometry market dynamics in the world mainly, the worldwide Flow Cytometry market is analyzed across major global regions. AMA also provides customized specific regional and country-level reports for the following areas.
• North America: United States, Canada, and Mexico.
• South & Central America: Argentina, Chile, Colombia and Brazil.
• Middle East & Africa: Saudi Arabia, United Arab Emirates, Israel, Turkey, Egypt and South Africa.
• Europe: United Kingdom, France, Italy, Germany, Spain, Belgium, Netherlands and Russia.
• Asia-Pacific: India, China, Japan, South Korea, Indonesia, Malaysia, Singapore, and Australia.
0 notes
Text
Electroporation Instruments Market Size, Share | Global Report 2030
The biotechnology, pharmaceutical, and contract research industries all primarily use electroporation technologies. It is applied in microbiology to modify prokaryotic cells by introducing artificial DNA sequences into them. Since the pharmaceutical sector is expanding quickly, so too is the demand for electroporation equipment.
Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/electroporation-instruments-market/
The electroporation devices have undergone significant technological developments in the last few years, and end users are becoming more accustomed to using them in hospital laboratories and university research centers. The expansion of the electroporation instrument market will be fueled by the rising incidence of chronic diseases like cancer, HIV, and others during the anticipated time frame. The global electroporation instruments market, which was estimated to be worth USD 185.1 million in 2022, is expected to expand to USD 288.9 million by 2030, with a CAGR of 5.7% over the forecast period of 2022–2030.
In the upcoming years, growth is also predicted to be fueled by the increasing number of R&D projects undertaken by various organizations to enhance this technology.
Increasing Prevalence of chronic diseases, high demand from biotechnology & pharmaceutical industry to boost Electroporation instruments Market
The expansion of the electroporation instrument market will be fueled by the rising incidence of chronic diseases like cancer, HIV, and others during the anticipated time frame. For instance, the World Health Organization’s 2022 report states that cancer was the biggest cause of death globally, accounting for about 10 million deaths in that year.
The pharmaceutical industry uses electroporation instruments to create monoclonal antibodies that are used in the production of medicines as well as in the manufacturing process to treat diseases. During the COVID crisis, the use of pharmaceutical drugs also increased to reduce stress, leading to an increase in the prevalence of the common cold and flu, which is driving the market. Also, since biotechnology firms concentrate more on creating goods that will help the human species survive and guarantee a healthy existence, demand for electroporation is rising quickly.
In order to create targeted, sequence-specific alternations across the DNA, researchers are increasingly incorporating a variety of technologically sophisticated processes into gene editing. Some well-known examples of cutting-edge gene editing technologies include transcription activator-like effector nucleases (TALENs), CRISPR-associated (Cas), proteins, and clustered regularly-interspaced short palindromic repeats (CRISPR). Increase in such R&D activities is anticipated to lead to a rise in the use of electroporation devices in the ensuing years.
North America to spearhead the Electroporation instruments market
Due to a surge in large firms’ R&D spending and an increase in clinical trials, North America dominated the global market in 2022. Because to their simplicity and effectiveness when compared to other traditional procedures like microinjection or chemical transfection, electroporation tools are frequently employed for research.
Increasing demand of electroporation in drug discovery & development process: In North America, both public and private institutions are making significant investments in healthcare infrastructure and research and development to cope up with the increasing number of patients suffering from various chronic diseases.
Favorable Regulatory Environment: The regulatory climate in North America is improving. Pharmaceutical businesses are finding it simpler to launch new drugs since regulatory agencies are creating clearer policies and procedures for the clearance of these therapies.
Increasing awareness in population: Increasing understanding of the advantages of electroporation among scientists and researchers.
Growing demand by pharmaceutical & biotechnology industry: The pharmaceutical and biotechnology industries are experiencing an increase in demand for effective, high-throughput screening techniques.
Technology advancement: Instruments for electroporation that have undergone technological developments that improve their performance and flexibility.
Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/electroporation-instruments-market/
Competitive Insights
Companies operating in the Electroporation instruments market have adopted several growth strategies to expand their market share and increase their revenue. Some of the key growth strategies adopted by these companies are: –
BEX Co. Ltd
Celetrix LLC
Merck KGaA
Eppendorf AG
Harvard Bioscience Inc. (BTX)
Thermo Fisher Scientific, Inc
Bio-Rad Laboratories
MaxCyte Inc.
Lonza Group, and Mirus Bio LLC
Guangzhou Tingmay Beauty Equipment Co., Ltd
ALLFOND INDUSTRIAL LIMITED
Shanghai Apolo Medical Technology Co., Ltd
0 notes
Text
Global Transfection Reagents and Equipment Market Is Estimated To Witness High Growth Owing To Growing Demand for Gene Therapy
The Global Transfection Reagents and Equipment Market is estimated to be valued at US$1,066.5 million in 2022 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: Transfection reagents and equipment are used in the process of introducing nucleic acids into cells. They play a crucial role in molecular biology research, gene therapy, and biopharmaceutical production. These products offer several advantages such as efficient DNA transfer, high transfection rates, low cytotoxicity, and compatibility with various cell types. The need for these products arises from the increasing demand for gene therapy and the growing focus on precision medicine. Transfection reagents and equipment enable researchers to study gene functions, protein expression, and cellular processes, leading to advancements in the understanding and treatment of various diseases. B) Market Key Trends: One key trend observed in the Transfection Reagents and Equipment market is the growing demand for gene therapy. Gene therapy has emerged as a promising approach for the treatment of genetic disorders, cancer, and other diseases. It involves the delivery of therapeutic genes into target cells to correct genetic abnormalities or enhance cellular functions. Transfection reagents and equipment play a crucial role in the efficient delivery of therapeutic genes, making them an essential component of gene therapy. The advancements in gene editing technologies like CRISPR-Cas9 have further fueled the demand for transfection reagents and equipment, as they enable precise and efficient gene editing. For example, CRISPR-Cas9 technology has shown great promise in treating sickle cell disease, a genetic disorder characterized by abnormal hemoglobin production. Researchers used transfection reagents to deliver CRISPR-Cas9 components into the bone marrow cells of a patient and successfully corrected the genetic mutation underlying the disease. This breakthrough highlights the transformative potential of gene therapy and the importance of transfection reagents and equipment in enabling such advancements. C) PEST Analysis: Political: The political landscape can influence the Transfection Reagents and Equipment market. Government regulations and policies related to genetic research and gene therapy can impact the development and commercialization of transfection reagents and equipment. Economic: Economic factors, such as healthcare expenditure, funding for research and development, and availability of healthcare infrastructure, can impact the demand for transfection reagents and equipment. Social: Social factors, including increasing awareness about genetic disorders, advancements in healthcare technologies, and the need for personalized medicine, are driving the adoption of transfection reagents and equipment. Technological: Technological advancements in gene editing technologies, such as CRISPR-Cas9, are fueling the demand for transfection reagents and equipment. Continuous innovation in transfection reagents and equipment is also driving market growth. D) Key Takeaways: Paragraph 1: The Global Transfection Reagents And Equipment Market Size is expected to witness high growth, exhibiting a CAGR of 9.3% over the forecast period. This growth is attributed to increasing demand for gene therapy, driven by advancements in gene editing technologies like CRISPR-Cas9. For example, the successful correction of genetic mutations underlying diseases using transfection reagents and equipment highlights their importance in gene therapy. Paragraph 2: Regionally, North America is expected to dominate the Transfection Reagents and Equipment market due to its well-established healthcare infrastructure, significant investments in research and development, and strong presence of key market players. Europe is also expected to witness substantial growth owing to increasing government support for genetic research and rising adoption of gene therapy.
#Transfection Reagents and Equipment Market#Transfection Reagents and Equipment#Transfection Reagents and Equipment Market Forecast
0 notes
Text
Transfection Technologies Market Growing by Increasing Market Share with Leading Players| Inovio Pharmaceuticals Inc., POLYPLUS TRANSFECTION.
Transfection Technologies Market is an approach to produce exogenous nucleic acids such as DNA, RNA or oligonucleotide into cells. Such nucleic acids can be transferred by polymeric or lipid transfection reagents which promote the cellular absorption. This method is widely used for genomic studies (cell representation, testing, RNA interference, in vitro research) but can be conducted for bio-production (vaccine and protein manufacturing) or medicinal reasons (animal cell treatment). Nucleic acid delivery to cells can be accomplished by distinct physical techniques, such as electroporation, sonoporation or microinjection; however, these procedures are comparatively hazardous to cells. Transfection with chemical substances is a better option for maintaining healthy cell feasibility.
Global transfection technologies market is registering a substantial CAGR of 9.74% in the forecast period of 2019-2026. This rise in the market can be attributed to surge in research & development in the field of cell based therapies and massive funds by government and private players.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-transfection-technologies-market
Competitive Analysis: Global Transfection Technologies Market
Few of the major competitors currently working in Global Transfection Technologies Market are Lonza., Promega Corporation., Sigma-Aldrich Co. , Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc. , Roche Molecular Systems, Inc., QIAGEN, Inovio Pharmaceuticals, Inc., POLYPLUS TRANSFECTION, Mirus Bio LLC, Takara Bio Inc., SignaGen Laboratories, MaxCyte, Inc., Genlantis Inc., Techulon, BioAstrum Corporation., Altogen Biosystems, OZ Biosciences, Boca Scientific, Inc., Biontex Laboratories GmbH. , and others.
Key Pointers Covered in the Global Transfection Technologies Market Trends and Forecast to 2026
Global Transfection Technologies Market New Sales Volumes
Global Transfection Technologies Market Replacement Sales Volumes
Global Transfection Technologies Market Installed Base
Global Transfection Technologies Market By Brands
Global Transfection Technologies Market Size
Global Transfection Technologies Market Procedure Volumes
Global Transfection Technologies Market Product Price Analysis
Global Transfection Technologies Market Healthcare Outcomes
Global Transfection Technologies Market Cost of Care Analysis
Global Transfection Technologies Market Regulatory Framework and Changes
Global Transfection Technologies Market Prices and Reimbursement Analysis
Global Transfection Technologies Market Shares in Different Regions
Recent Developments for Global Transfection Technologies Market Competitors
Global Transfection Technologies Market Upcoming Applications
Global Transfection Technologies Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=global-transfection-technologies-market
Key Developments in the Market:
In December 2018, Polyplus-transfection SA declared the release of PEIpro-GMP, a transfection reagent for medical and industrial lentivirus and adeno-associated disease (AAV) tissue & DNA therapy. This reagent was launched to promote the medical stage and the commercialization stage of manufacturing.
In May 2018, Altogen Biosystems released a new version of AltoFect, a second generation transfection reagent for the hard-to-transfect cell lines to primary cell types. AltoFect transfection reagent appears to have up to 85 percent efficiency of transfection in difficult-to-transfect cells, like B-cells, T-cells and primary cell cultures. This reagent allows scientists to solve difficulties and constraints linked to primary cells and difficult-to-transfect cell lines.
Market Drivers
Surge in research & development in the field of cell based therapies is contributing to the growth of the market
Massive funds by government and private players is boosting the growth of the market
Growing occurrences of cancer diseases is propelling the growth of the market
Increasing number of obese and overweight population is driving the growth of the market
Market Restraints
Cost of transfection technology instruments is hampering the growth of the market
Hazard of negative reaction with the cell is hindering the growth of the market
Home brew reagents restricts sale of business supply which is restricting the growth of the market
Speak to Author :
https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-transfection-technologies-market
Research Methodology: Global Transfection Technologies Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Key insights in the report:
Complete and distinct analysis of the market drivers and restraints
Key Market players involved in this industry
Detailed analysis of the Market Segmentation
Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report Here:
Blood Screening Market
North America Antimicrobial Susceptibility Testing Market
#Transfection Technologies Market#Transfection Technologies Market share#Transfection Technologies Market size#Transfection Technologies Market trends#Transfection Technologies Market news#Transfection Technologies Market report#Transfection Technologies Market growth
0 notes
Photo
Transfection Technologies Market - Industry Trends and Forecast to 2026
Global transfection technologies market is registering a substantial CAGR of 9.74% in the forecast period of 2019-2026. This rise in the market can be attributed to surge in research & development in the field of cell based therapies and massive funds by government and private players.
Get Sample Report at :
https://bit.ly/3fGuodw
#Transfection Technologies Market#Transfection Technologies Market share#Transfection Technologies Market size#Transfection Technologies Market trends#Transfection Technologies Market news#Transfection Technologies Market report
0 notes
Text
Transfection Technologies Market Strategic Insights and key Business Influencing Factors | Major Players – Roche Molecular Systems, Inc., QIAGEN, Inovio Pharmaceuticals, Inc., POLYPLUS TRANSFECTION.
Transfection Technologies Market is an approach to produce exogenous nucleic acids such as DNA, RNA or oligonucleotide into cells. Such nucleic acids can be transferred by polymeric or lipid transfection reagents which promote the cellular absorption. This method is widely used for genomic studies (cell representation, testing, RNA interference, in vitro research) but can be conducted for bio-production (vaccine and protein manufacturing) or medicinal reasons (animal cell treatment). Nucleic acid delivery to cells can be accomplished by distinct physical techniques, such as electroporation, sonoporation or microinjection; however, these procedures are comparatively hazardous to cells. Transfection with chemical substances is a better option for maintaining healthy cell feasibility.
Global transfection technologies market is registering a substantial CAGR of 9.74% in the forecast period of 2019-2026. This rise in the market can be attributed to surge in research & development in the field of cell based therapies and massive funds by government and private players.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-transfection-technologies-market
Competitive Analysis: Global Transfection Technologies Market
Few of the major competitors currently working in Global Transfection Technologies Market are Lonza., Promega Corporation., Sigma-Aldrich Co. , Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc. , Roche Molecular Systems, Inc., QIAGEN, Inovio Pharmaceuticals, Inc., POLYPLUS TRANSFECTION, Mirus Bio LLC, Takara Bio Inc., SignaGen Laboratories, MaxCyte, Inc., Genlantis Inc., Techulon, BioAstrum Corporation., Altogen Biosystems, OZ Biosciences, Boca Scientific, Inc., Biontex Laboratories GmbH. , and others.
Key Pointers Covered in the Global Transfection Technologies Market Trends and Forecast to 2026
Global Transfection Technologies Market New Sales Volumes
Global Transfection Technologies Market Replacement Sales Volumes
Global Transfection Technologies Market Installed Base
Global Transfection Technologies Market By Brands
Global Transfection Technologies Market Size
Global Transfection Technologies Market Procedure Volumes
Global Transfection Technologies Market Product Price Analysis
Global Transfection Technologies Market Healthcare Outcomes
Global Transfection Technologies Market Cost of Care Analysis
Global Transfection Technologies Market Regulatory Framework and Changes
Global Transfection Technologies Market Prices and Reimbursement Analysis
Global Transfection Technologies Market Shares in Different Regions
Recent Developments for Global Transfection Technologies Market Competitors
Global Transfection Technologies Market Upcoming Applications
Global Transfection Technologies Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=global-transfection-technologies-market
Key Developments in the Market:
In December 2018, Polyplus-transfection SA declared the release of PEIpro-GMP, a transfection reagent for medical and industrial lentivirus and adeno-associated disease (AAV) tissue & DNA therapy. This reagent was launched to promote the medical stage and the commercialization stage of manufacturing.
In May 2018, Altogen Biosystems released a new version of AltoFect, a second generation transfection reagent for the hard-to-transfect cell lines to primary cell types. AltoFect transfection reagent appears to have up to 85 percent efficiency of transfection in difficult-to-transfect cells, like B-cells, T-cells and primary cell cultures. This reagent allows scientists to solve difficulties and constraints linked to primary cells and difficult-to-transfect cell lines.
Market Drivers
Surge in research & development in the field of cell based therapies is contributing to the growth of the market
Massive funds by government and private players is boosting the growth of the market
Growing occurrences of cancer diseases is propelling the growth of the market
Increasing number of obese and overweight population is driving the growth of the market
Market Restraints
Cost of transfection technology instruments is hampering the growth of the market
Hazard of negative reaction with the cell is hindering the growth of the market
Home brew reagents restricts sale of business supply which is restricting the growth of the market
Speak to Author :
https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-transfection-technologies-market
Research Methodology: Global Transfection Technologies Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Key insights in the report:
Complete and distinct analysis of the market drivers and restraints
Key Market players involved in this industry
Detailed analysis of the Market Segmentation
Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report Here:
Blood Screening Market
North America Antimicrobial Susceptibility Testing Market
#Transfection Technologies Market#Transfection Technologies Market share#Transfection Technologies Market size#Transfection Technologies Market trends#Transfection Technologies Market news#Transfection Technologies Market report
0 notes
Text
Scaffold Technology Market Industry Share, Size, Growth, Demands, Revenue, Top Leaders and Forecast to 2028
Industry Analysis
The scaffold technology market is expected to witness market growth at a rate of 8.89% in the forecast period of 2021 to 2028 and is expected to reach 2,254.07 USD million by 2028.
Additionally, the credible Scaffold Technology Market report helps the manufacturer in finding out the effectiveness of the existing channels of distribution, advertising programs, or media, selling methods and the best way of distributing the goods to the eventual consumers. Taking up such market research report is all the time beneficial for any company whether it is a small scale or large scale, for marketing of products or services. It makes effortless for healthcare industry to visualize what is already available in the market, what market anticipates, the competitive environment, and what should be done to surpass the competitor.
Get a Free Sample of The Report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-scaffold-technology-market
Market Insights and Scope
Scaffolds can be defined as the artificial extracellular matrices that support the 3D tissue regenerations and accommodate cells. These can be either permanent or temporary matrices which offer mechanical, chemical and biological support for the tissue formation. Scaffold technology is applied to present 3D culture assays that involve cell to cell interactions, high throughput screening, cell to matrix interactions, transfections, and cell migration assays.
An international Scaffold Technology Market research report examines competitive companies and manufacturers in the global market. Competitive analysis carried out in this market report puts forth the moves of the key players in the healthcare industry such as new product launches, expansions, agreements, joint ventures, partnerships, and recent acquisitions. This market report puts light on various aspects of marketing research that range from important industry trends, market size, market share estimates, sales volume, emerging trends, product consumption, customer preferences, historic data along with future forecast and key player analysis. It studies market by product type, applications and growth factors.
Get full access to the report: https://www.databridgemarketresearch.com/reports/global-scaffold-technology-market
Industry Segmentation
The scaffold technology market is segmented on the basis of type, application, disease and end use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
On the basis of type, the scaffold technology market is segmented into hydrogels, wound healing, 3d bio printing, and immunomodulation. Hydrogels is further sub segmented into polymeric scaffolds, micropatterned surface microplates and nanofiber-based scaffolds.
On the basis of application, the scaffold technology market is segmented into stem cell therapy, regenerative medicine, and tissue engineering, drug discovery, and others.
On the basis of disease, the scaffold technology market is segmented into orthopaedics, musculoskeletal, and spine, cancer, skin and integumentary, dental, cardiology and vascular, neurology, urology, GI, gynaecology, and others.
On the basis of end use, the scaffold technology market is segmented into biotechnology and pharmaceutical industries, research laboratories and institutes, hospitals and diagnostic centers, and others.
Market Country Level Analysis
The countries covered in the scaffold technology market report are the
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
An influential Scaffold Technology Market research report displays an absolute outline of the market that considers various aspects such as product definition, customary vendor landscape, and market segmentation. Currently, businesses are relying on the diverse segments covered in the market research report to a great extent which gives them better insights to drive the business on the right track. The competitive analysis brings into light a clear insight about the market share analysis and actions of the key industry players. With this info, businesses can successfully make decisions about business strategies to accomplish maximum return on investment (ROI).
Industry Share Analysis
The major players covered in the scaffold technology market report are
Thermo Fisher Scientific, Merck KGaA, Tecan Trading AG, REPROCELL Inc., 3D Biotek LLC, BD, Medtronic, XANOFI, Molecular Matrix, Inc., Matricel GmbH,, 4titude, Pelobiotech Corning Incorporated, Akron Biotechnology LLC, Bioquote Ltd, Avacta Life Sciences Limited., Nanofiber Solutions, Vericel Corporation, NuVasive, Inc., Allergan plc, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Browse Related Reports@
Global Frozen Vegetables Market
South Africa Battery Market
Global Plant-Based Egg Market
Global Nutritional Beverages market
Spain Fuel Cards Market for Commercial Fleet
Europe Fall Detection System Market
About Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact: Data Bridge Market Research Tel: +1-888-387-2818 Email: [email protected]
#Scaffold Technology Market Growing Popularity#Scaffold Technology Market Global Leading Brands#Scaffold Technology Market drivers-advantages#Scaffold Technology Market Segmentation-CAGR rate#Scaffold Technology Market Demands-Size-Share-Top Trends#Scaffold Technology Market Industry-Competitors#Scaffold Technology Market Growth-Competition#Scaffold Technology Market 2028 by Types-Application#Scaffold Technology Market Healthcare Industry
0 notes
Text
Transfection Technologies Market - Forecast, 2022-2027
Transfection Technologies Market size is estimated to reach $1.7 billion by 2027, growing at a CAGR of 8.1% during the forecast period 2022-2027. Transfection can be delineated as a method taken into consideration to introduce naturally occurring chemical compounds that are nucleic acids into cells. Nucleic acids such as deoxyribonucleic acid and ribonucleic acid are considered to alter the genetic content of host cells. It isn’t a piece of cake to penetrate a cell and introduce foreign nucleic acids as the cellular membrane shields them from the outer environment. Therefore, several microbiology techniques like electroporation and magnet assisted transfection is used to broaden the porousness of the cell membrane so that chemicals or DNA can be introduced without any hindrance. The transfection technologies market outlook is exceptionally bewitching as they have a wide range of applications in coming across detailed biomarkers by getting the hang of molecular pathway of maladies and these biomarkers can be useful in the diagnosis of ailments like cancer. Far-reaching applications in protein production and vaccine development, proliferation in the prevalence of cancer and other chronic illnesses as the geriatric population is on a precipitous upsurge are the most prominent factors set to drive the growth of the Transfection Technologies Market for the period 2022-2027.
Report Coverage
The report: “Transfection Technologies Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Transfection Technologies Market.
By Application: Research (cancer research, biomedical research), Therapeutics, Protein production and studies, and others. By Method Type: Biological methods (virus-mediated transfection or transduction), Chemical based transfection (magnetic beads, Cationic amino acids and polymers, lipofection, cationic lipids, calcium phosphate, and others), Instrument based method (Biolistic particle delivery, laserfection, electroporation, direct microinjection, and others). By Technology: Biochemical, Physical, and Viral-Vector based Transfection. By End User: Hospitals, Research laboratories, Pharma and Biopharmaceutical firms, Academic institutions. By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).
Key Takeaways
Geographically, the North America Transfection Technologies Market accounted for the highest revenue share in 2021. However, Asia-pacific is poised to dominate the market over the period 2022-2027.
Heightening research and development activities associated with novel discoveries of drugs and transfection techniques and enlarging demand for precise therapeutic procedures are said to be preeminent drivers driving the growth of the Transfection Technologies Market. Moreover, the grim requirement of innumerable hard cash and cell damage incidences due to transfection are said to reduce the market growth.
Detailed analysis of the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Transfection Technologies Market report.
Transfection Technologies Market Share, By Geography (%) in 2021
For More Details on This Report - Request for Sample
Transfection Technologies Market Segment Analysis-By Technology Type
The Transfection Technologies Market based on the technology type can be further segmented into biological methods (virus-mediated transfection or transduction), chemical-based transfection (magnetic beads, cationic amino acids and polymers, lipofection, cationic lipids, calcium phosphate, and others), Instrument based method (Biolistic particle delivery, laserfection, electroporation, direct microinjection, and others). The biological and chemical-based method segment held the largest share in 2021. The growth is owing to the high preciseness of the viral vector as compared to gene transduction as virus-mediated transfection makes use of a viral vector to deliver DNA and RNA into the cells. Biological methods are used frequently owing to their meticulousness in gene delivery. Moreover, viral vector in transduction extends the advantages of easy permeability in cells that are quite rigid to bisect making it easy to accomplish transgene countenance in vivo. On another hand, chemical-based methods are very cost-effective and easy to use making them the first choice of many researchers. However, the Instrument-based segment is estimated to be the fastest-growing segment with a CAGR of 9.8% over the forecast period 2022-2027. This growth is owing to their flexibility and ease of working with a diversity of cells. Moreover, these methods are quite well-organized therefore can be operated in alive organisms.
Transfection Technologies Market Segment Analysis-By End User
The Transfection Technologies Market based on end-user can be further segmented into Hospitals, Research laboratories, Pharma and Biopharmaceutical firms, and Academic institutions. The pharmaceutical and biopharmaceutical along segment held the largest share in 2021. The growth is owing to round-the-clock research activities in an attempt to develop an effective cure for COVID-19 vaccines. The demand for acetaminophen and ivermectin as corona cases are spiking ensuring billions of dollars to pharmaceutical companies. As a result, companies have heightened their quest for vaccine developments where transfection technologies play a crucial role. Moreover, this same segment is estimated to be the fastest-growing segment with a CAGR of 9.3% over the forecast period 2022-2027. This growth is owing to the ineffectiveness of vaccines against mutated variants of the COVID-19. The pharma and biopharma companies are slogging through too much as the prevalence of cancer is expected to reach epidemic proportions in foreseeable future.
Transfection Technologies Market Segment Analysis-By Geography
The Transfection Technologies Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 38% of the overall market in 2021. The growth in this segment is owing to the factors such as the presence of state-of-the-art research laboratories and top-flight pharmaceutical players that are assisting in research and development at a relentless pace. The full-fledged economies of North American states subject them to spending an incalculable amount of riches to develop contemporary cures. Moreover, plunging incidences of obesity and breast cancer among people in the US is another big factor in the dominance of this segment in the transfection technologies market. Nevertheless, the Asia-pacific segment is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to heightened incidences of infections attributed to poor intake and bizarre eating habits, especially in nations like China, Thailand, and India. On another hand, due to the upsurging old-age population cardiovascular illnesses are griping this continent. Nevertheless, the rising wealth of countries is encouraging them to refine their existing healthcare infrastructure and research proficiencies.
Transfection Technologies Market Drivers
Expanding incidences of chronic illnesses are Anticipated to Boost Product Demand
The accruing chronic maladies and viral infections are the primary reason behind broadening mortality rates and the number of hospitalizations around the globe. With declining, immunities people are turning more prone to such illnesses. As of 2021, more than 14% of an adult residing in the U.S. were reported with more than 1 chronic ailment. In addition to that, 43-44% of millennials who are in their early 40s are afflicted with some sort of chronic condition. Besides, around 1.9 million cases of cancer were found worldwide which eventually led to more than 600,000 fatalities in 2021. Moreover, over 130,000 deaths are being reported every year in the US due to lung cancer. Considering these trends, the demand for transfection technologies has heightened in recent years.
Heightened flows of riches in research and development as communicable viruses are griping the world are Expected to Boost Product Demand
The private players in the market have increased their efforts to overcome the drawbacks of existing transfection technologies. For instance, Thermo Fisher scientific a major player in the transfection technologies market increase its research spending by more than $150 million in 2020 when it allocated around $1,181 million to research and development. The numbers are bound to rise with the rising profit of pharmaceutical companies due to the pandemic and are anticipated to drive the market forward.
Transfection Technologies Market Challenges
The exorbitant cost of instruments and drawback of transfection methods is Anticipated to Hamper Market Growth
The instruments required to perform the transfection process are expensive which can be a challenge for the market. Even though chemical transfection methods are slightly cost-effective but they are prone to errors also. Moreover, the usage of chemicals like calcium phosphate can affect cell functioning adversely. The total DNA amount used in calcium phosphate transfection is usually 10–50 ?g in 450 ?L sterile water and 50 ?L of 2.5 M CaCl2 per 10-cm dish but varies widely among plasmid preparations as well as with different cells and media. Methods like electroporation and microinjections are considered harmful as they can mutilate the cells during the penetration of the cellular membrane due to larger pores and ion imbalance which is anticipated to cripple the growth of the transfection technologies market.
Transfection Technologies Industry Outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Transfection Technologies Market. Key companies in this market are-
Lonza Group
Qiagen
Sigma Aldrich
Thermo Fisher
Bio-Rad Laboratories Inc.
Life technologies
Roche Holding AG
Promega Corporation
SignaGen Laboratories
Polyplus-Transfection
Recent Developments
On February 3, 2022, Polypus, a provider of transfection reagents acquired e-Zyvec, a France-based provider of DNA design and production services for custom-made DNA vectors to expand their expertise in the plasmid DNA vector engineering.
On April 15, 2021, US-based company “Thermo Fisher Scientific” which is famous for its reagent and other instrument supplies concluded the acquisition of US-based CRO “Pharmaceutical Product Development.” A payment of $17.4 billion was made to PPD. The acquisition strengthens the clinical research portfolio of Thermo Fisher.
On April 9, 2020, California, United States-based company “Bio-Rad Laboratories” which develops special technology for life science successfully acquired the company “Celsee.” Celsee is a US-based firm that deals in transfection technologies. The financials
#Transfection Technologies Market share#Transfection Technologies Market size#Transfection Technologies Market forecast
0 notes
Text
Electroporation Instruments Market Size, Share | Global Report 2030
The biotechnology, pharmaceutical, and contract research industries all primarily use electroporation technologies. It is applied in microbiology to modify prokaryotic cells by introducing artificial DNA sequences into them. Since the pharmaceutical sector is expanding quickly, so too is the demand for electroporation equipment.
Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/electroporation-instruments-market/
The electroporation devices have undergone significant technological developments in the last few years, and end users are becoming more accustomed to using them in hospital laboratories and university research centers. The expansion of the electroporation instrument market will be fueled by the rising incidence of chronic diseases like cancer, HIV, and others during the anticipated time frame. The global electroporation instruments market, which was estimated to be worth USD 185.1 million in 2022, is expected to expand to USD 288.9 million by 2030, with a CAGR of 5.7% over the forecast period of 2022–2030.
In the upcoming years, growth is also predicted to be fueled by the increasing number of R&D projects undertaken by various organizations to enhance this technology.
Increasing Prevalence of chronic diseases, high demand from biotechnology & pharmaceutical industry to boost Electroporation instruments Market
The expansion of the electroporation instrument market will be fueled by the rising incidence of chronic diseases like cancer, HIV, and others during the anticipated time frame. For instance, the World Health Organization’s 2022 report states that cancer was the biggest cause of death globally, accounting for about 10 million deaths in that year.
The pharmaceutical industry uses electroporation instruments to create monoclonal antibodies that are used in the production of medicines as well as in the manufacturing process to treat diseases. During the COVID crisis, the use of pharmaceutical drugs also increased to reduce stress, leading to an increase in the prevalence of the common cold and flu, which is driving the market. Also, since biotechnology firms concentrate more on creating goods that will help the human species survive and guarantee a healthy existence, demand for electroporation is rising quickly.
In order to create targeted, sequence-specific alternations across the DNA, researchers are increasingly incorporating a variety of technologically sophisticated processes into gene editing. Some well-known examples of cutting-edge gene editing technologies include transcription activator-like effector nucleases (TALENs), CRISPR-associated (Cas), proteins, and clustered regularly-interspaced short palindromic repeats (CRISPR). Increase in such R&D activities is anticipated to lead to a rise in the use of electroporation devices in the ensuing years.
North America to spearhead the Electroporation instruments market
Due to a surge in large firms’ R&D spending and an increase in clinical trials, North America dominated the global market in 2022. Because to their simplicity and effectiveness when compared to other traditional procedures like microinjection or chemical transfection, electroporation tools are frequently employed for research.
Increasing demand of electroporation in drug discovery & development process: In North America, both public and private institutions are making significant investments in healthcare infrastructure and research and development to cope up with the increasing number of patients suffering from various chronic diseases.
Favorable Regulatory Environment: The regulatory climate in North America is improving. Pharmaceutical businesses are finding it simpler to launch new drugs since regulatory agencies are creating clearer policies and procedures for the clearance of these therapies.
Increasing awareness in population: Increasing understanding of the advantages of electroporation among scientists and researchers.
Growing demand by pharmaceutical & biotechnology industry: The pharmaceutical and biotechnology industries are experiencing an increase in demand for effective, high-throughput screening techniques.
Technology advancement: Instruments for electroporation that have undergone technological developments that improve their performance and flexibility.
Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/electroporation-instruments-market/
Competitive Insights
Companies operating in the Electroporation instruments market have adopted several growth strategies to expand their market share and increase their revenue. Some of the key growth strategies adopted by these companies are: –
BEX Co. Ltd
Celetrix LLC
Merck KGaA
Eppendorf AG
Harvard Bioscience Inc. (BTX)
Thermo Fisher Scientific, Inc
Bio-Rad Laboratories
MaxCyte Inc.
Lonza Group, and Mirus Bio LLC
Guangzhou Tingmay Beauty Equipment Co., Ltd
ALLFOND INDUSTRIAL LIMITED
Shanghai Apolo Medical Technology Co., Ltd
0 notes
Text
Cell Counting Market In – Depth Analysis of Industry Share, Size, Growth Outlook up to 2027
Market Highlights
According to MRFR analysis, Cell Counting Market Sizeis expected to register a CAGR of 5.8% during the forecast period and was valued at USD 8.47 Billion in 2018.
Cell counts are vital to monitor cell health and proliferation rate, and assess immortalization or transformation. It is also important for seeding cells for subsequent experiments, infection or transfection, and preparing cell-based assays. Cell counting is widely used in research institutes, hospitals, pharmaceutical and biotechnology companies, and others.
Various factors are adding to the global cell counting market share. These factors, as per the new MRFR report, include increasing use of automated hematology analyzers and high-throughput flow cytometry, development of improved image analysis and enhanced solutions, rising prevalence of blood disorders and target diseases, and increasing research and development expenditure. Additional factors adding market growth include new product launches and increasing use of cell counting instruments in neuroscience, immunology, and cancer biology.
On the contrary, product recalls, and the soaring price of advanced cell counting systems are factors that may limit the cell counting market growth over the forecast period.
Regional Analysis
Based on region, the global cell counting machine report covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period. Factors propelling the cell counting market growth in the region include huge support from the government in the likes of grants and funds, availability of products that are technologically advanced, presence of well-established pharmaceutical & biotechnology industry, and rising prevalence of cancer.
The cell counting market in Europe is predicted to hold the second-largest share over the forecast period. Factors propelling the cell counting market growth in the region include growing healthcare expenditure, the presence of top manufacturers, support and funding for the healthcare industry by government bodies, and increasing research and development.
The cell counting market in the APAC region will grow at the fastest pace over the forecast period for the increasing drug development researches and developing healthcare infrastructure.
The cell counting market in the MEA is predicted to have the smallest share over the forecast period for limited development of healthcare facilities and low per capita disposable incomes.
Market Segmentation:
The Market Research Future Report provides an inclusive segmental analysis of the global cell counting market based on end user, application, and product.
By product, the global cell counting market is segmented into instruments and consumables. Of these, the consumables segment will lead the market over the forecast period for its repeated purchase over instrument products.
By applications, the global cell counting market is segmented into clinical and diagnostic applications, research applications, and others. Of these, the research application segment will dominate the market over the forecast period for the increased funding for stem cell research.
By end user segments, the global cell counting market is segmented into research institutes, hospitals, pharmaceutical, and biotechnology companies, and others. Of these, pharmaceutical and biotechnology companies will have a major share in the market over the forecast period as they are largely used in the R&D of new drugs & therapies.
Key Players
Some of the Key Players in the Global Cell Counting Market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Logos Biosystems, Inc. (South Korea), Olympus Corporation (Japan), Agilent Technologies, Inc. (US), PerkinElmer, Inc. (US), Sysmex Corporation (Japan), Abbott Laboratories (US), and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
0 notes
Text
Genomics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2030
Genomics Market is appreciated to demonstrate a substantial upswing of a CAGR of 19.40% during the forecasted period of 2021 to 2030. The Genomics Market was valued at USD 23.5 billion in 2021 and is estimated to display a significant improvement to reach USD 137.16 billion by 2030.
Genomics is the study of genomes, and it includes DNA sequencing, recombinant DNA, and bioinformatics for sequencing, assembling, and analysing genome structure and functions. The growing use of NGS (Next-Generation Sequencing) in cancer research, as well as the entrance of new businesses and start-ups, will fuel the industry's revenue growth.
In terms of technology, the sequencing segment's genomics market share will grow due to their increased involvement in research in animal breeding, agriculture, and human genomes. Sequencing technologies are widely employed in scientific research, modern molecular biology, and diagnostic medicine due to their advantages such as fast speed, scalability, and ultra-high throughput.
Request a sample copy of Genomics Market: https://wemarketresearch.com/sample-request/genomics-market/48/
The rise in use of genomics in drug R&D, increased competition in the global pharmaceutical industry, surge in demand for genetically modified animals and plants, constantly lowering prices of genetic procedures, market growth initiatives taken by private and public organisations, rise in demand for nucleic acid sequencing, and entry of new players into the genomics market are the key factors driving the market's growth. Furthermore, the rising popularity of customised medicine and the growing popularity of alliances between research institutes and companies are likely to provide new growth prospects for genomics market players. However, the shortage of experienced specialists, the high costs of genomics equipment, and a lack of awareness in some countries are expected to limit the industry's expansion.
Global Genomics Market- Segment Analysis
Genomics Market based on Drugs: Deliverable
Among the deliverable’s segment the products category was dominant factor with a revenue share of 69.3%.
Products
• Instruments/Systems/Software
• Consumables & Reagents
Services
• NGS-based Services
• Core Genomics Services
• Biomarker Translation Services
• Computational Services
• Others
Genomics Market by Application & Technology:
Functional Genomics
• Real-time PCR
• Transfection
• SNP Analysis
• Mutational Analysis
• Microarray Analysis
• RNA Interference
Pathway Analysis
• Microarray Analysis
• Bead-based Analysis
• Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
• Real-time PCR
Biomarker Discovery
• DNA Sequencing
• Microarray Analysis
• Real-time PCR
• Mass Spectrometry
• Statistical Analysis
• Bioinformatics
Epigenetics
• Bisulfite Sequencing
• Microarray Analysis
• Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
• Methylated DNA Immunoprecipitation (MeDIP)
• High Resolution Melt (HRM)
• Chromatin Accessibility Assays
• Others
Genomics Market by End use:
• Pharmaceutical and Biotechnology Companies
• Hospitals and Clinics
• Academic and Government Institutes
• Clinical Research
• Other
Purchase Global Genomicss Market Research Report:- https://wemarketresearch.com/purchase/genomics-market/48/?license=single
Genomics Market: Competitive Landscape
Companies are focusing on development and inauguration of new products and collaboration with other entities to rise the market share. The main purpose of this collaboration is to manage the work flows. Some of the prominent companies are as follows Thermo Fisher Scientific, Inc.; Agilent Technologies; Beijing Genomics Institute (BGI); Bio-Rad Laboratories; Oxford Nanopore Technologies; Pacific Biosciences of California, Inc.; QIAGEN N.V.; Quest diagnostics; Myriad Genetics, Inc.; Eppendorf AG; Eurofins Scientific; Color; 23andMe, Inc. Danaher Corporation; F. Hoffmann-La Roche Ltd.; GE Healthcare; Illumina, Inc.
FAQs
1)What is the Genomics market growth?
2) Which product segment accounts for the highest market share in the Genomics market?
3) Does the Genomics market company is profiled in the report?
4) Which are the top companies hold the market share in Genomics market?
5) How can I get sample reports/company profiles for the Genomics market?
About We Market Research
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
Contact Us:
We Market Research
Phone: +1(929)-450-2887
Email: [email protected]
Web:
https://wemarketresearch.com/
0 notes
Text
Flow Cytometry Market Share by 2029: Upcoming Trends and Analysis
Flow Cytometry Market Scope and Size
· On the basis of technology, the flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry.
On the basis of products, the market is segmented into categorized into reagents and conFlow Cytometry Market is grow at a CAGR 4.45%in the forecast 2022 to 2029.
· sumables, flow cytometry instruments, accessories and services. Reagents and consumables is been further sub segmented into antibodies, dyes, beads and others. Instruments has been further sub segmented into cell analysers and cell sorters. Services has been further sub segmented into filters, laser devices, detectors and others.
· On the basis of application, the flow cytometry market is segmented into research applications, clinical application and industrial applications. Research applications market is further sub segmented into pharmaceutical and biotechnology, immunology, apoptosis, cell sorting/ screening, cell cycle analysis, cell transfection/viability, cell counting and others. Pharmaceutical and biotechnology are further sub segmented into drug discovery, stem cell research and in vitro toxicity testing. The clinical application are further sub segmented into cancer, hematology, immunodeficiency diseases, organ transplantation, and others.
· On the basis of end user, the flow cytometry market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals, clinical testing laboratories, blood bank and others.
Get the sample copy of Report here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-flow-cytometry-market
Flow Cytometry Market Country Level Analysis
The flow cytometry market is analysed, and market size insights and trends are provided by country, technology, products, application and end user as referenced above.
The countries covered in the flow cytometry market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Competitive Landscape and Flow Cytometry Market Share Analysis
The flow cytometry market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the flow cytometry market.
MAJOR TOC OF THE REPORT
Chapter One: Flow Cytometry Market Overview
Chapter Two: Manufacturers Profiles
Chapter Three: Flow Cytometry Market Competition, by Players
Chapter Four: Global Flow Cytometry Market Size by Regions
Chapter Five: North Flow Cytometry Market by Countries
Chapter Six: Europe Flow Cytometry Market Revenue by Countries
Chapter Seven: Asia-Pacific Flow Cytometry Market by Countries
Chapter Eight: South America Flow Cytometry Market by Countries
Chapter Nine: Middle East and Africa Flow Cytometry Market Equipment by Countries
Chapter Ten: Global Flow Cytometry Market Segment by Type
Chapter Eleven: Global Flow Cytometry Market Segment by Application
Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-flow-cytometry-market
Some of the major players operating in the flow cytometry market are Bio-Rad Laboratories, Inc., Miltenyi Biotec Sysmex Partec GmbH, BIOMÉRIEUX, Mechatronics, Apogee Flow Systems Ltd., Stratedigm, Inc., Sony Biotechnology Inc., BD., Thermo Fisher Scientific Inc., Merck KGaA, ACEA BIO, Agilent Technologies, Luminex Corporation., Enzo Life Sciences, Inc., Beckman Coulter, Inc., and Takara Bio Inc., among others.
Access Full Report https://www.databridgemarketresearch.com/reports/global-flow-cytometry-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Reports@
Revenue Cycle Management (RCM) Market
Stem Cell manufacturing Market
0 notes
Photo
Transfection Technologies Market - Industry Trends and Forecast to 2026
Global transfection technologies market is registering a substantial CAGR of 9.74% in the forecast period of 2019-2026. This rise in the market can be attributed to surge in research & development in the field of cell based therapies and massive funds by government and private players.
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-transfection-technologies-market
#Transfection Technologies Market#Transfection Technologies Market share#Transfection Technologies Market size#Transfection Technologies Market trends#Transfection Technologies Market news#Transfection Technologies Market report#Transfection Technologies Market growth
0 notes